Dr Reddys Laboratories Stock Beta

RDY Stock  USD 72.31  0.49  0.67%   
Dr Reddys Laboratories fundamentals help investors to digest information that contributes to Dr Reddys' financial success or failures. It also enables traders to predict the movement of RDY Stock. The fundamental analysis module provides a way to measure Dr Reddys' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Dr Reddys stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

RDY Beta Analysis

Dr Reddys' Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
 2021 2022 2023 2024 (projected)
Other Current Liabilities41.6B48.9B56.2B59.0B
Total Assets296.7B322.9B371.3B206.1B

Beta

 = 

Covariance

Variance

More About Beta | All Equity Analysis

Current Dr Reddys Beta

    
  0.35  
Most of Dr Reddys' fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Dr Reddys Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

RDY Beta Driver Correlations

Understanding the fundamental principles of building solid financial models for Dr Reddys is extremely important. It helps to project a fair market value of RDY Stock properly, considering its historical fundamentals such as Beta. Since Dr Reddys' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Dr Reddys' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Dr Reddys' interrelated accounts and indicators.
0.970.96-0.071.0-0.14-0.130.920.990.910.98-0.16-0.2-0.050.961.00.990.990.331.00.040.960.03-0.070.19-0.14-0.180.10.030.020.01
0.971.00.090.97-0.04-0.20.970.960.880.95-0.04-0.160.040.910.970.980.960.320.98-0.090.920.11-0.020.12-0.2-0.140.140.140.120.16
0.961.00.160.96-0.01-0.180.970.930.880.920.02-0.120.10.880.960.970.950.30.96-0.150.90.150.040.07-0.18-0.110.130.20.180.2
-0.070.090.16-0.090.7-0.010.17-0.180.03-0.220.880.540.82-0.28-0.08-0.09-0.1-0.16-0.06-0.85-0.260.690.71-0.550.040.4-0.130.810.820.67
1.00.970.96-0.09-0.16-0.130.910.990.90.98-0.18-0.23-0.060.960.990.990.990.320.990.030.960.03-0.060.24-0.14-0.20.10.030.010.0
-0.14-0.04-0.010.7-0.160.08-0.13-0.230.01-0.270.80.640.86-0.28-0.14-0.19-0.17-0.43-0.15-0.75-0.270.710.73-0.340.120.58-0.620.430.490.22
-0.13-0.2-0.18-0.01-0.130.08-0.28-0.120.19-0.150.310.550.01-0.04-0.17-0.16-0.08-0.27-0.170.19-0.14-0.070.14-0.171.00.42-0.52-0.26-0.23-0.25
0.920.970.970.170.91-0.13-0.280.890.770.89-0.03-0.210.030.810.920.930.90.410.93-0.120.850.11-0.08-0.01-0.27-0.140.310.250.230.3
0.990.960.93-0.180.99-0.23-0.120.890.891.0-0.26-0.26-0.170.980.990.990.980.360.980.160.99-0.1-0.170.27-0.14-0.230.13-0.1-0.12-0.06
0.910.880.880.030.90.010.190.770.890.870.070.140.020.90.890.890.910.130.880.030.870.060.140.170.19-0.02-0.09-0.02-0.01-0.02
0.980.950.92-0.220.98-0.27-0.150.891.00.87-0.31-0.3-0.210.980.980.990.980.380.980.190.99-0.13-0.230.29-0.17-0.250.16-0.13-0.15-0.07
-0.16-0.040.020.88-0.180.80.31-0.03-0.260.07-0.310.850.72-0.32-0.19-0.2-0.18-0.35-0.18-0.7-0.320.70.76-0.490.360.68-0.30.60.640.48
-0.2-0.16-0.120.54-0.230.640.55-0.21-0.260.14-0.30.850.4-0.26-0.23-0.24-0.23-0.34-0.24-0.26-0.270.380.59-0.340.60.75-0.330.180.210.16
-0.050.040.10.82-0.060.860.010.03-0.170.02-0.210.720.4-0.24-0.06-0.11-0.07-0.37-0.04-0.9-0.240.690.76-0.450.040.34-0.530.640.70.3
0.960.910.88-0.280.96-0.28-0.040.810.980.90.98-0.32-0.26-0.240.950.960.970.240.940.240.98-0.16-0.190.38-0.06-0.290.07-0.2-0.22-0.14
1.00.970.96-0.080.99-0.14-0.170.920.990.890.98-0.19-0.23-0.060.950.990.980.351.00.050.960.02-0.10.19-0.18-0.190.120.020.010.0
0.990.980.97-0.090.99-0.19-0.160.930.990.890.99-0.2-0.24-0.110.960.990.990.350.990.080.97-0.03-0.130.22-0.17-0.210.16-0.02-0.040.03
0.990.960.95-0.10.99-0.17-0.080.90.980.910.98-0.18-0.23-0.070.970.980.990.240.980.040.960.02-0.070.24-0.09-0.220.070.01-0.010.0
0.330.320.3-0.160.32-0.43-0.270.410.360.130.38-0.35-0.34-0.370.240.350.350.240.350.30.37-0.34-0.47-0.16-0.29-0.010.51-0.11-0.20.02
1.00.980.96-0.060.99-0.15-0.170.930.980.880.98-0.18-0.24-0.040.941.00.990.980.350.020.950.05-0.080.18-0.18-0.190.130.060.050.03
0.04-0.09-0.15-0.850.03-0.750.19-0.120.160.030.19-0.7-0.26-0.90.240.050.080.040.30.020.24-0.82-0.770.350.15-0.250.3-0.82-0.84-0.47
0.960.920.9-0.260.96-0.27-0.140.850.990.870.99-0.32-0.27-0.240.980.960.970.960.370.950.24-0.19-0.220.33-0.16-0.250.15-0.2-0.23-0.12
0.030.110.150.690.030.71-0.070.11-0.10.06-0.130.70.380.69-0.160.02-0.030.02-0.340.05-0.82-0.190.7-0.17-0.030.42-0.260.780.820.45
-0.07-0.020.040.71-0.060.730.14-0.08-0.170.14-0.230.760.590.76-0.19-0.1-0.13-0.07-0.47-0.08-0.77-0.220.7-0.080.170.26-0.390.640.640.32
0.190.120.07-0.550.24-0.34-0.17-0.010.270.170.29-0.49-0.34-0.450.380.190.220.24-0.160.180.350.33-0.17-0.08-0.21-0.570.08-0.35-0.4-0.29
-0.14-0.2-0.180.04-0.140.121.0-0.27-0.140.19-0.170.360.60.04-0.06-0.18-0.17-0.09-0.29-0.180.15-0.16-0.030.17-0.210.46-0.52-0.22-0.19-0.21
-0.18-0.14-0.110.4-0.20.580.42-0.14-0.23-0.02-0.250.680.750.34-0.29-0.19-0.21-0.22-0.01-0.19-0.25-0.250.420.26-0.570.46-0.270.130.150.04
0.10.140.13-0.130.1-0.62-0.520.310.13-0.090.16-0.3-0.33-0.530.070.120.160.070.510.130.30.15-0.26-0.390.08-0.52-0.270.130.040.28
0.030.140.20.810.030.43-0.260.25-0.1-0.02-0.130.60.180.64-0.20.02-0.020.01-0.110.06-0.82-0.20.780.64-0.35-0.220.130.130.970.76
0.020.120.180.820.010.49-0.230.23-0.12-0.01-0.150.640.210.7-0.220.01-0.04-0.01-0.20.05-0.84-0.230.820.64-0.4-0.190.150.040.970.68
0.010.160.20.670.00.22-0.250.3-0.06-0.02-0.070.480.160.3-0.140.00.030.00.020.03-0.47-0.120.450.32-0.29-0.210.040.280.760.68
Click cells to compare fundamentals
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Competition

In accordance with the recently published financial statements, Dr Reddys Laboratories has a Beta of 0.351. This is 59.19% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The beta for all United States stocks is notably lower than that of the firm.

RDY Beta Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Dr Reddys' direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Dr Reddys could also be used in its relative valuation, which is a method of valuing Dr Reddys by comparing valuation metrics of similar companies.
Dr Reddys is currently under evaluation in beta category among related companies.

Dr Reddys Institutional Holders

Institutional Holdings refers to the ownership stake in Dr Reddys that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Dr Reddys' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Dr Reddys' value.
Shares
Gqg Partners Llc2023-12-31
437 K
Ameriprise Financial Inc2023-09-30
434.5 K
Millennium Management Llc2023-09-30
361.6 K
Grantham, Mayo, Van Otterloo & Co., Llc2023-12-31
329.1 K
Lazard Asset Management Llc2023-09-30
306.1 K
Acadian Asset Management Llc2023-09-30
270.3 K
Schroder Investment Management Group2023-12-31
266.7 K
Mondrian Investment Partners Ltd2023-09-30
216.1 K
Assenagon Asset Management Sa2023-12-31
196.1 K
Blackrock Inc2023-12-31
M
Royal Bank Of Canada2023-09-30
2.1 M
As returns on the market increase, Dr Reddys' returns are expected to increase less than the market. However, during the bear market, the loss of holding Dr Reddys is expected to be smaller as well.

RDY Fundamentals

About Dr Reddys Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Dr Reddys Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dr Reddys using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dr Reddys Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Reddys Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. Reddys Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India. Dr Reddys operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on New York Stock Exchange. It employs 24795 people.

Currently Active Assets on Macroaxis

When determining whether Dr Reddys Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dr Reddys' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dr Reddys Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dr Reddys Laboratories Stock:
Check out Dr Reddys Piotroski F Score and Dr Reddys Altman Z Score analysis.
Note that the Dr Reddys Laboratories information on this page should be used as a complementary analysis to other Dr Reddys' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Complementary Tools for RDY Stock analysis

When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Is Dr Reddys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dr Reddys. If investors know RDY will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dr Reddys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.103
Dividend Share
40
Earnings Share
3.75
Revenue Per Share
272.4618
Quarterly Revenue Growth
0.066
The market value of Dr Reddys Laboratories is measured differently than its book value, which is the value of RDY that is recorded on the company's balance sheet. Investors also form their own opinion of Dr Reddys' value that differs from its market value or its book value, called intrinsic value, which is Dr Reddys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dr Reddys' market value can be influenced by many factors that don't directly affect Dr Reddys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dr Reddys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dr Reddys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dr Reddys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.